What is In Vitro Fertilization Test Market?
Before the beginning of IVF, women undergo various screenings or testing. This involves taking a blood sample and testing it for the level of follicle-stimulating hormone.
The market study is being classified by Type (Ovarian Reserve Testing, Semen Analysis, Infectious Disease Screening, Practice (Mock) Embryo Transfer and Uterine Exam) and major geographies with country level break-up.
The Mayo Clinic (United States), ZyMōt Fertility (United States), Monash IVF (Australia), Ferring Pharmaceuticals (Switzerland), CARE Fertility (United Kingdom), CooperSurgical, Inc. (United States), Vitrolife (Sweden), UVA Health (United States) and Merck Group (Germany) are some of the key players profiled in the study.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global In Vitro Fertilization Test market throughout the predicted period.
Analyst at AMA have segmented the market study of Global In Vitro Fertilization Test market by Type, Application and Region.
On the basis of geography, the market of In Vitro Fertilization Test has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Obesity and Infertility Rate Due to Mental Stress and Change in Eating Habits
- Increasing Investment for Research and Development of Advanced Technologies and Treatment Methods
- High Cost Associated With In Vitro Fertilization Can Create Hurdles for the Market
- Increased Adoption of In Vitro Fertilization in Developed Countries
- Less Awareness and Unwillingness to Adopt In Vitro Fertilization in Rural Areas
Market Leaders and some development strategies
In July 2021, Vitrolife acquired Igenomix from the private equity group EQT. Igenomix develops molecular genetic testing diagnostic for reproductive medicine, including in vitro fertilization (IVF) and rare diseases. The acquisition of Igenomix’s portfolio of reproductive genetic testing services along with its IVF device portfolio will allow Vitrolife to offer an IVF platform to potentially deliver personalised genetic information to patients globally and further improve clinical practices in infertility, women’s health, and rare diseases.
In July 2018, Merck launched the QBOX IVF and the new Geri Assess 2.0 to serve the needs of its customers and become the preferred treatment partner for all IVF stakeholders and assisted reproductive treatment (ART) clinics. The new modules help clinics simplify embryo assessment, improve consistency across users and reduce the time spent in annotations by automatically detecting key events in embryo and blastocyst development.
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, In Vitro Fertilization Treatment Providers, In Vitro Fertilization Test Drugs & Devices Manufacturers, Suppliers and Distributors of In Vitro Fertilization Test Drugs & Devices, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and Others
Frequently Asked Questions (FAQ):
1. Which factors would majorly drive the In Vitro Fertilization Test Market?
"Increasing Obesity and Infertility Rate Due to Mental Stress and Change in Eating Habits" is seen as one of major growth factors of In Vitro Fertilization Test Market in years to come.
2. Can we have customized study for In Vitro Fertilization Test Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
3. Which region will lead the Global In Vitro Fertilization Test Market?
United States will lead In Vitro Fertilization Test Market in coming years.